Review
NANC neural control of airway smooth muscle tone

https://doi.org/10.1016/0306-3623(95)02142-6Get rights and content

Abstract

  • 1.

    1. This review addresses the functional role of the nonadrenergic, noncholinergic (NANC) neural response in the control of airway smooth muscle tone.

  • 2.

    2. Functional data from guinea pig airways in vitro indicate that the level of basal smooth muscle tone determines the direction and magnitude of the NANC neural response such that it can stabilise tone.

  • 3.

    3. The NANC stabilising effect on tone is adjustable through variation in impulse frequency and the NANC stabilising effect is also powerful; it can abolish near-maximum differences in tone.

  • 4.

    4. Cholinergic activation increases the level towards which the NANC responses tend to adjust tone.

  • 5.

    5. Adrenergic activation reduces the level towards which the NANC responses tend to adjust tone via β-adrenoceptors.

  • 6.

    6. NANC neural activation, with or without simultaneous adrenergic or cholinergic activation, can stabilise tone at low, intermediate or high levels with a high degree of accuracy.

  • 7.

    7. Evidence from other investigators on effects of putative NANC neurotransmitters supports the idea of functional interactions within the NANC system in the airways.

  • 8.

    8. It remains to be confirmed whether or not NANC responses play a stabilising role in the control of airway smooth muscle tone in vivo and in higher mammals.

References (142)

  • K.F. Kerrebijn

    Beta Agonists

  • J.-W. Lammers et al.

    Nonadrenergic bronchodilator mechanisms in normal human subjects in vivo

    J. Appl. Physiol.

    (1988)
  • A. Lindén et al.

    In vitro characteristics of spontaneous airway tone in the guinea pig

    Acta Phys. Scand.

    (1991)
  • J.M. Lundberg et al.

    Co-existence of peptide HI (PHI) and VIP in nerves regulating blood flow and bronchial smooth muscle tone in various mammals including man

    Peptides

    (1984)
  • J.O. Lötvall et al.

    Airway effects of direct left-sided cervical vagal stimulation in patients with complex partial seizures

    Epilepsy Res.

    (1992)
  • I.M. Adcock et al.

    Inhibitory NANC responses and VIP mRNA levels in asthmatic and denervated human lung

    Am. Rev. Respir. Dis.

    (1991)
  • H. Aizawa et al.

    Effect of endogenous tachykinins on neuro-effector transmission of vagal nerve in guinea-pig tracheal tissue

    Respiration

    (1990)
  • R.G.G. Andersson et al.

    The excitatory non-cholinergic, non-adrenergic nervous system of the guinea-pig airways

    Eur. J. Respir. Dis.

    (1983)
  • C.L. Armour et al.

    Nedocromil sodium inhibits substance P-induced potentiation of cholinergic neural responses in the isolated innervated rabbit trachea

    J. Auton. Pharmacol.

    (1991)
  • T.R. Bai et al.

    Effect of an inhibitor of nitric oxide synthase on neural relaxation of human bronchi

    Am. J. Physiol.

    (1993)
  • J. Barlinski et al.

    Modulation by theophylline and enprophylline of the excitatory non-cholinergic transmission in guinea-pig bronchi

    Eur. Respir. J.

    (1992)
  • P.J. Barnes

    Endogenous plasma adrenaline in asthma

    Eur. J. Respir. Dis.

    (1983)
  • P.J. Barnes

    Neuropeptides and asthma

    Am. Rev. Respir. Dis.

    (1991)
  • L. Barthó et al.

    Peripheral effects of opioid drugs on capsaicin-sensitive neurones of the guinea-pig bronchus and rabbit ear

    Naunyn-Schmiederberg's Archiv. Pharmacol.

    (1987)
  • M.G. Belvisi et al.

    Opoid modulation of non-cholinergic neural bronchoconstriction in guinea-pig in vivo

    Br. J. Pharm.

    (1988)
  • M.G. Belvisi et al.

    Modulation of cholinergic neurotransmission in guinea-pig airways by opoids

    Br. J. Pharm.

    (1991)
  • M.G. Belvisi et al.

    Inhibitory NANC nerves in human tracheal smooth muscle: a quest for the neurotransmitter

    J. Appl. Physiol.

    (1992)
  • A. Ben-Jebria et al.

    In vitro responsiveness to neuropeptides in human passively sensitized airways

    Am. Rev. Respir. Dis.

    (1993)
  • C. Bertrand et al.

    Involvement of tachykinins in antigen-induced bronchoconstriction in sensitized guinea-pigs

    Eur. Resp. J.

    (1993)
    C. Bertrand et al.

    Involvement of tachykinins in antigen-induced bronchoconstriction in sensitized guinea-pigs

    Eur. Resp. J.

    (1993)
    C. Bertrand et al.

    Involvement of tachykinins in antigen-induced bronchoconstriction in sensitized guinea-pigs

    Eur. Resp. J.

    (1993)
  • A.R. Cameron et al.

    Electrical and anatomic characteristics of cells of ferret paratracheal ganglion

    Am. J. Physiol.

    (1984)
  • B.J. Canning et al.

    The parasympathetic ganglia mediating NANC relaxations of guinea-pig trachealis are extrinsic to the trachea

    Am. Rev. Resp. Dis.

    (1993)
  • J.R. Carstairs et al.

    Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung

    J. Pharm. Exp. Ther.

    (1986)
  • L.O. Cardell et al.

    Pituitary adenylate cyclase activating peptide (PACAP) in guinea-pig lung: distribution and dilatory effects

    Reg. Peptides

    (1991)
  • L.O. Cardell et al.

    Low plasma concentrations of VIP and elevated levels of other neuropeptides during exacerbations of asthma

    Eur. Respir. J.

    (1994)
  • R.F. Coburn et al.

    Evidence for nonadrenergic inhibitory nerves in the guinea pig trachealis muscle

    Am .J. Physiol.

    (1973)
  • R.A. Coleman et al.

    A non-adrenergic inhibitory nervous pathway in guinea-pig trachea

    Br. J. Pharm.

    (1974)
  • C. Davis et al.

    Control of human airway smooth muscle: in vitro studies

    J. Appl. Physiol.

    (1982)
  • J.C. de Jongste et al.

    In vitro responses of airways from an asthmatic patient

    Eur. J. Respir. Dis.

    (1987)
  • J.C. de Jongste et al.

    Cholinergic and non-adrenergic inhibitory nerve-mediated responses of isolated human airways from patients with and without COPD or asthma

  • J.C. de Jongste et al.

    Nonneural components in the response of fresh human airways to electrical field stimulation

    J. Appl. Physiol.

    (1987)
  • R.D. Dey et al.

    Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cats and human subjects

    Cell. Tiss. Res.

    (1981)
  • R.D. Dey et al.

    Colocalization of vasoactive intestinal peptide and nitric oxide synthase in neurons of the ferret trachea

    Neuroscience

    (1993)
  • J.M. Doidge et al.

    Adrenergic and non-adrenergic inhibitory nerves in mammalian airways

    J. Auton. Nerv. System

    (1982)
  • J.L. Ellis et al.

    Inhibition by L-NG-Nitro-L-Arginine of nonadrenergic-noncholinergic-mediated relaxations of human isolated central and peripheral airways

    Am. Rev. Respir. Dis.

    (1992)
  • T.M. Farne et al.

    Decrease in airway's nonadrenergic non-cholinergic inhibitory system in allergen sensitized rabbits

    Am. Rev. Respir. Dis.

    (1993)
  • N. Frossard et al.

    μ-Opioid receptors modulate non-cholinergic constrictor nerves in guinea-pig airways

    Eur.J. Pharm.

    (1987)
  • R.W. Fuller et al.

    Bronchoconstrictor response to inhaled capsaicin in humans

    J. Appl. Physiol.

    (1985)
  • M.A. Ghatei et al.

    Regulatory peptides in the respiratory tract of Macaca Fascicularis

    Thorax

    (1987)
  • N.J. Gross

    Cholinergic control

  • N. Grundström et al.

    Pharmacological characterisation of the autonomous innervation of the guinea pig tracheobronchial smooth muscle

    Acta Pharmac. Toxicol.

    (1981)
  • Cited by (13)

    • Sex, Cells, and Asthma

      2021, Mayo Clinic Proceedings
      Citation Excerpt :

      The roles of sympathetic and particularly parasympathetic innervation in regulation of airway tone and reactivity are well recognized, as are roles in defensive reflexes of the upper airway, such as coughing and sneezing.152 Human airways are innervated by nonadrenergic, noncholinergic (NANC) pathways involving excitatory bronchoconstriction through tachykinins, substance P, and neurokinin A and bronchodilation, whereas inhibitory NANC pathways involve vasoactive intestinal peptide and NO.153-159 Thus, imbalances between excitatory and inhibitory NANC pathways can contribute to AHR.153,160 No specific information is available regarding how sex steroids influence NANC pathways and their potential contribution to sex differences in asthma.

    • COPD Therapy: Beyond Conventional Pharmacology

      2020, Archivos de Bronconeumologia
    • Sex steroid signaling: Implications for lung diseases

      2015, Pharmacology and Therapeutics
      Citation Excerpt :

      Human airway has non-adrenergic, non-cholinergic (NANC) innervation which mediates (excitatory) bronchoconstriction via tachykinins, substance P and neurokinin A. The inhibitory component of NANC mediates bronchodilation via vasoactive intestinal peptide and NO (Lammers et al., 1992; Belvisi et al., 1995; Ward et al., 1995; Linden, 1996; Mackay et al., 1998; van der Velden & Hulsmann, 1999; Joos et al., 2000). Neuronal NOS in NANC nerve fibers generates NO from arginine which then induces ASM relaxation.

    • Pharmacological characterization of the interaction between the dual phosphodiesterase (PDE) 3/4 inhibitor RPL554 and glycopyrronium on human isolated bronchi and small airways

      2015, Pulmonary Pharmacology and Therapeutics
      Citation Excerpt :

      As expected, the loss of Emax to acetylcholine in the presence of the competitive antagonist glycopyronnium, resembles the response observed for indirectly acting substances that release endogenous intermediaries, the concentrations of which are the limiting factor and therefore cannot compete with antagonist-occupied receptors [21]. In addition, this peculiar profile might be caused by the intrinsic characteristic of bronchial contraction induced by transmural stimulation of postganglionic nerve fibers that is characterized by the release of both acetylcholine, through activation of parasympathetic nerves, and tachykinins such as substance P (SP), neurokinin A (NKA) and calcitonin gene-related peptide (CGRP), through activation of excitatory non-adrenergic non-cholinergic (NANC) mechanisms, although the latter system is of greater significance in animals than in human airways [41–46]. The alternative pA2 analysis suggests that glycopyrronium was a very potent compound in reducing the bronchial contraction induced by EFS, although the pA2 calculated during our study was slightly different compared with the pIC50 = 10.4 detected in a previous study on the pharmacological characterization of the potency of glycopyrronium in human isolated bronchi [47].

    • The relationship between dose-dependent antitussive and bronchodilatory effects of Opilia celtidifolia polysaccharide and nitric oxide in guinea pigs

      2010, International Journal of Biological Macromolecules
      Citation Excerpt :

      In addition to the classical cholinergic bronchoconstrictor and adrenergic bronchodilator neural mechanisms, there is a variety of species which are neither adrenergic nor cholinergic, the non-adrenergic, non-cholinergic (NANC) mechanisms. NANC neural mechanisms play an important role in the maintenance and regulation of bronchomotor tone, either via the direct effects of the transmitters released or by neuromodulation of autonomic control mechanisms [22]. Excitatory NANC (e-NANC) bronchoconstrictor responses are mediated by the release of sensory neuropeptides from e-NANC nerves, which release tachykinins such as substance P (SP), neurokinin A (NKA) and the peptide calcitonin gene-related peptide (CGRP).

    View all citing articles on Scopus

    This work was supported by Hermann Krefting's Foundation, the Swedish Heart-Lung Fund, the Swedish Society of Medicine, the Swedish Medical Research Council (B94-19F-10715-01) and Tore Nilsson's Foundation.

    View full text